Drug:
Reaction: DEVICE MALFUNCTION
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940099 |
US |
69 | 1 |
Drug dose omission by device, Device malfunction, |
||||
PEGFILGRASTIM, |
||||
| 2 | 26940254 |
US |
69 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 3 | 26940676 |
US |
66 | 2 |
Condition aggravated, Diarrhoea, Nausea, Drug dose omission by device, Device malfunction, Device mechanical issue, Device physical property issue, |
||||
ABALOPARATIDE, |
||||
| 4 | 26940692 |
EU |
50 | 2 |
Asphyxia, Circumstance or information capable of leading to medication error, Device malfunction, |
||||
| 5 | 26940751 |
US |
2 | |
Incorrect dose administered by device, Device failure, Device malfunction, Device mechanical issue, No adverse event, |
||||
LIRAGLUTIDE, |
||||
| 6 | 26941573 |
US |
43 | |
Dermatitis atopic, Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 7 | 26941719 |
US |
79 | |
Injection site haemorrhage, Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 8 | 26941745 |
US |
||
No adverse event, Device malfunction, No adverse event, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 9 | 26941821 |
US |
82 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 10 | 26941947 |
BR |
70 | 2 |
Asphyxia, Renal failure, Product use issue, Dengue fever, Osteoporosis, Device malfunction, Off label use, |
||||
BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, CALCIUM, AMLODIPINE BESYLATE, |
||||
| 11 | 26942190 |
US |
||
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 12 | 26942212 |
US |
62 | 2 |
Hip fracture, Multiple sclerosis, Device malfunction, Fall, Gait disturbance, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 13 | 26942594 |
US |
||
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 14 | 26943174 |
US |
34 | |
Incorrect dose administered, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 15 | 26943321 |
US |
1 | |
Device malfunction, Drug dose omission by device, Feeling abnormal, |
||||
ORAL SEMAGLUTIDE, |
||||
| 16 | 26943833 |
US |
35 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 17 | 26943984 |
US |
5 | 1 |
Incorrect dose administered, Wrong technique in device usage process, Device malfunction, |
||||
LONAPEGSOMATROPIN-TCGD, |
||||
| 18 | 26944574 |
US |
1 | |
Injection site swelling, Accidental exposure to product, Exposure via skin contact, Device malfunction, |
||||
DUPILUMAB, |
||||
| 19 | 26945144 |
US |
75 | 2 |
Device loosening, Device malfunction, Product dose omission issue, Wrong technique in product usage process, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 20 | 26945196 |
US |
64 | |
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 21 | 26945292 |
US |
67 | |
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 22 | 26945536 |
US |
2 | |
Drug dose omission by device, Product use in unapproved indication, Device malfunction, Device delivery system issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, SPIRONOLACTONE, DESVENLAFAXINE SUCCINATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, THYROID, PORCINE, |
||||
| 23 | 26945780 |
US |
69 | 2 |
Therapeutic response unexpected, Device malfunction, |
||||
ABALOPARATIDE, |
||||
| 24 | 26945949 |
US |
70 | 2 |
Device defective, Drug dose omission by device, Device malfunction, Needle issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ORAL SEMAGLUTIDE, |
||||
| 25 | 26945956 |
US |
69 | 2 |
Device malfunction, Therapeutic response unexpected, |
||||
ABALOPARATIDE, |
||||
| 26 | 26945976 |
US |
77 | 2 |
Chills, Tremor, Device malfunction, Incorrect product administration duration, Product dose omission issue, |
||||
ABALOPARATIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CALCIUM, FISH OIL, LISINOPRIL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SERTRALINE HYDROCHLORIDE, |
||||
| 27 | 26946139 |
US |
2 | |
Weight increased, Hyperhidrosis, Sleep disorder, Paraesthesia, Formication, Oedema peripheral, Joint swelling, Injection site urticaria, Night sweats, Nausea, Dizziness, Headache, Bone pain, Fatigue, Arthralgia, Abdominal pain upper, Abdominal distension, Device malfunction, |
||||
ABALOPARATIDE, ROSUVASTATIN, |
||||
| 28 | 26946369 |
US |
84 | 2 |
Injection site pain, Injection site reaction, Fatigue, Device malfunction, Drug dose omission by device, Product dose omission in error, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 29 | 26946627 |
US |
84 | 1 |
Drug dose omission by device, Product supply issue, Device malfunction, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 30 | 26946764 |
US |
44 | 1 |
Product dose omission issue, Device issue, Device malfunction, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 31 | 26947106 |
US |
45 | 2 |
Device malfunction, Device leakage, Drug dose omission by device, |
||||
| 32 | 26947193 |
US |
73 | 2 |
Product dose omission issue, Device defective, Device malfunction, |
||||
ABALOPARATIDE, |
||||
| 33 | 26947197 |
US |
75 | 2 |
Depressed mood, Muscular weakness, Musculoskeletal discomfort, Blood urea increased, Nausea, Back pain, Blood calcium increased, Device malfunction, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, FENOFIBRATE, IRON, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, EVOLOCUMAB, ACYCLOVIR, AMOXICILLIN, FAMOTIDINE, EPINEPHRINE, ALPRAZOLAM, SERTRALINE HYDROCHLORIDE, CEPHALEXIN, CETIRIZINE HYDROCHLORIDE, ALBUTEROL SULFATE, IPRATROPIUM BROMIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CYCLOSPORINE, |
||||
| 34 | 26947311 |
US |
66 | 2 |
Product dose omission in error, Device malfunction, Device issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 35 | 26947489 |
US |
2 | |
Urticaria, Allergy to plants, Device malfunction, Drug dose omission by device, Device difficult to use, |
||||
ABALOPARATIDE, |
||||
| 36 | 26947692 |
US |
30 | |
Device malfunction, Incorrect dose administered, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 37 | 26947822 |
US |
59 | 2 |
Skin irritation, Herpes zoster, Device malfunction, Product use issue, Drug dose omission by device, Product administered at inappropriate site, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 38 | 26948009 |
US |
71 | |
Pruritus, Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 39 | 26934421 |
US |
63 | 2 |
Product dose omission issue, Device malfunction, No adverse event, |
||||
TOCILIZUMAB, HYDROXYCHLOROQUINE SULFATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FOLIC ACID, MELOXICAM, ESOMEPRAZOLE MAGNESIUM, MONTELUKAST SODIUM, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 40 | 26934616 |
GB |
58 | |
Uveitis, Device malfunction, Product leakage, Accidental exposure to product, Exposure via skin contact, Drug ineffective, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 41 | 26934816 |
US |
35 | 2 |
Device malfunction, |
||||
PEGFILGRASTIM, |
||||
| 42 | 26934983 |
US |
||
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 43 | 26935214 |
US |
2 | |
Device use issue, Medication error, Device malfunction, Product cleaning inadequate, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 44 | 26935420 |
US |
66 | 2 |
Device malfunction, |
||||
PEGFILGRASTIM, PEGFILGRASTIM, |
||||
| 45 | 26935524 |
BR |
1 | |
Nasopharyngitis, Pneumonia, Immunodeficiency, Off label use, Device malfunction, |
||||
BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, |
||||
| 46 | 26935530 |
US |
55 | |
Device malfunction, Incorrect dose administered, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 47 | 26935702 |
US |
71 | |
Device malfunction, Product dose omission issue, Intentional product use issue, |
||||
NEMOLIZUMAB-ILTO, LISINOPRIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ZOLPIDEM TARTRATE, |
||||
| 48 | 26935765 |
US |
||
Device delivery system issue, Device malfunction, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 49 | 26935806 |
US |
60 | 1 |
Off label use, Device malfunction, Product dose omission issue, No adverse event, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 50 | 26936025 |
US |
1 | |
Injection site pain, Device malfunction, |
||||
DUPILUMAB, ALPRAZOLAM, CEFIXIME, FLUTICASONE PROPIONATE, MELOXICAM, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN, |
||||
| 51 | 26936130 |
US |
73 | |
Incorrect dose administered, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 52 | 26936181 |
US |
82 | |
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 53 | 26936195 |
US |
10 | 2 |
Product dose omission issue, Device malfunction, Device defective, No adverse event, |
||||
OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 54 | 26937814 |
US |
76 | 2 |
Drug delivery system malfunction, Dyspnoea, Product dose omission issue, Device malfunction, Product quality issue, |
||||
ALBUTEROL SULFATE, |
||||
| 55 | 26938421 |
US |
51 | 2 |
Psoriatic arthropathy, Device malfunction, Product dose omission issue, Hidradenitis, Condition aggravated, Product leakage, Inappropriate schedule of product administration, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 56 | 26938566 |
US |
64 | 2 |
Device malfunction, Ear infection, Injection site discharge, Injection site swelling, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 57 | 26938719 |
US |
2 | 1 |
Device malfunction, |
||||
SOMATROPIN, |
||||
| 58 | 26938941 |
US |
2 | |
Product container seal issue, Drug dose omission by device, Product use in unapproved indication, Product administered at inappropriate site, Device malfunction, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DUPILUMAB, AMLODIPINE BESYLATE, |
||||
| 59 | 26938952 |
US |
72 | 2 |
Injection site bruising, Product dose omission issue, Therapeutic product effect incomplete, Therapy interrupted, Product use complaint, Device malfunction, Product use issue, Device defective, |
||||
ABALOPARATIDE, |
||||
| 60 | 26939131 |
US |
52 | 2 |
Device malfunction, |
||||
PEGFILGRASTIM, PEGFILGRASTIM, |
||||
| 61 | 26939265 |
US |
2 | |
Dermal cyst, Balance disorder, Musculoskeletal stiffness, Nausea, Injection site erythema, Contusion, Drug dose omission by device, Device malfunction, Needle issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ERGOCALCIFEROL, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, AMLODIPINE, BIOTIN, BUPROPION HYDROCHLORIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FOLIC ACID, HYDROXYCHLOROQUINE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 62 | 26939501 |
US |
2 | |
Adverse event, Dizziness, Product supply issue, Product dose omission issue, Device malfunction, Device issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 63 | 26939663 |
US |
79 | 2 |
Dizziness, Palpitations, Heart rate increased, Device mechanical issue, Device malfunction, Product dose omission issue, Product administered at inappropriate site, |
||||
ABALOPARATIDE, |
||||
| 64 | 26939814 |
US |
2 | |
Fat redistribution, Injection site mass, Device malfunction, Product use issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, VALACYCLOVIR HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 65 | 26931540 |
US |
26 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 66 | 26932110 |
US |
60 | |
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 67 | 26932178 |
US |
70 | |
Intentional product use issue, Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 68 | 26932179 |
EU |
||
Syncope, Incorrect dose administered by device, Device malfunction, |
||||
| 69 | 26932239 |
US |
||
No adverse event, Device malfunction, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 70 | 26932267 |
US |
||
Device malfunction, No adverse event, Device failure, No adverse event, Device failure, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 71 | 26932339 |
US |
||
Device malfunction, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 72 | 26932347 |
US |
1 | |
No adverse event, Device malfunction, No adverse event, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 73 | 26933082 |
US |
33 | |
Device malfunction, Incorrect dose administered, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 74 | 26933084 |
US |
81 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 75 | 26933098 |
US |
61 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 76 | 26933180 |
US |
2 | |
Drug dose omission by device, Device malfunction, Device leakage, Device leakage, Product quality issue, |
||||
| 77 | 26933279 |
US |
68 | |
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 78 | 26927049 |
US |
2 | |
Device malfunction, Brain fog, Dyspnoea, Pain in extremity, Anxiety, Dyspepsia, Blood pressure increased, Diarrhoea, Nausea, Dehydration, Feeling hot, Dry mouth, Oedema, Fatigue, Therapy non-responder, |
||||
TREPROSTINIL, TREPROSTINIL, ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS), PROGESTERONE, FUROSEMIDE, FAMOTIDINE, SPIRONOLACTONE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, MAGNESIUM OXIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, MACITENTAN, SELENIUM, PSYLLIUM HUSK, ARNICA MONTANA FLOWER, ERGOCALCIFEROL, VALERIAN, MOMETASONE FUROATE, MOMETASONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SOTATERCEPT-CSRK, TADALAFIL, EPOPROSTENOL, SACCHAROMYCES CEREVISIAE, TIZANIDINE HYDROCHLORIDE, OXYGEN, 0XYGEN, CALCIUM CARBONATE, ANTACID, LEVONORGESTREL, |
||||
| 79 | 26927303 |
US |
2 | |
Device malfunction, Accidental exposure to product, Product dose omission issue, Injection site bruising, Injection site haemorrhage, Off label use, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
| 80 | 26927415 |
US |
75 | |
Drug dose omission by device, Device malfunction, Wrong technique in product usage process performed in error, Device deposit issue, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 81 | 26927596 |
US |
25 | 2 |
Device defective, Device malfunction, Device leakage, Injection site erythema, Drug dose omission by device, |
||||
| 82 | 26927700 |
US |
36 | 1 |
Colitis ulcerative, Device malfunction, Incorrect dose administered, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, URSODIOL, URSOSIOL, |
||||
| 83 | 26928306 |
US |
2 | |
Accidental exposure to product, Blood glucose increased, Device leakage, Device malfunction, Drug dose omission by device, |
||||
INSULIN ASPART, |
||||
| 84 | 26928333 |
US |
||
Device malfunction, |
||||
GUSELKUMAB, |
||||
| 85 | 26928492 |
US |
7 | 2 |
Device malfunction, Lack of injection site rotation, |
||||
LONAPEGSOMATROPIN-TCGD, |
||||
| 86 | 26928569 |
US |
14 | 2 |
Pneumonia, Gait disturbance, Delusion, Product dose omission issue, Device malfunction, Device issue, Product temperature excursion issue, Product availability issue, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 87 | 26928864 |
US |
||
No adverse event, Device malfunction, No adverse event, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 88 | 26928961 |
US |
70 | 2 |
Product dose omission issue, Neutrophil count decreased, Device malfunction, Neutrophil count decreased, Product dose omission issue, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, CETUXIMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 89 | 26928979 |
US |
||
No adverse event, Device malfunction, No adverse event, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 90 | 26929109 |
US |
86 | 2 |
Wrong technique in product usage process, Device delivery system issue, Device malfunction, Device loosening, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 91 | 26929268 |
US |
83 | 2 |
Wrong technique in device usage process, Product prescribing issue, Device malfunction, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 92 | 26929998 |
US |
62 | 2 |
Psoriatic arthropathy, Device malfunction, Product dose omission issue, Therapeutic response unexpected, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 93 | 26930280 |
US |
43 | 2 |
Product dose omission issue, Wrong technique in device usage process, Product delivery mechanism issue, Device malfunction, Product cleaning inadequate, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 94 | 26930696 |
US |
2 | |
Asthma, Cough, Device malfunction, Vision blurred, Device use error, Product delivery mechanism issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 95 | 26930754 |
US |
||
Device malfunction, No adverse event, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 96 | 26930968 |
US |
12 | 1 |
Device malfunction, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 97 | 26921549 |
US |
||
Visual impairment, Drug ineffective, Blood glucose increased, Device malfunction, |
||||
INSULIN ASPART, |
||||
| 98 | 26921610 |
US |
37 | 2 |
Injection site injury, Product storage error, Skin pressure mark, Device malfunction, Incorrect dose administered by device, |
||||
| 99 | 26922497 |
US |
1 | |
Device malfunction, |
||||
NITRIC OXIDE, NITRIC OXIDE, |
||||
| 100 | 26922499 |
US |
||
Device malfunction, |
||||
NITRIC OXIDE, NITRIC OXIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
